Hage M - Search Results

1

Cure of Barrett's carcinoma by ifosfamide chemotherapy.

Siersema PD, Hage M, van der Gaast A, van Dekken H, Kok TC, Tilanus HW, Kuipers EJ. Siersema PD, et al. Among authors: hage m. Eur J Gastroenterol Hepatol. 2002 Nov;14(11):1261-4. doi: 10.1097/00042737-200211000-00016. Eur J Gastroenterol Hepatol. 2002. PMID: 12439123

2

5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial.

Hage M, Siersema PD, van Dekken H, Steyerberg EW, Haringsma J, van de Vrie W, Grool TE, van Veen RL, Sterenborg HJ, Kuipers EJ. Hage M, et al. Gut. 2004 Jun;53(6):785-90. doi: 10.1136/gut.2003.028860. Gut. 2004. PMID: 15138203 Free PMC article. Clinical Trial.

3

Oesophageal cancer incidence and mortality in patients with long-segment Barrett's oesophagus after a mean follow-up of 12.7 years.

Hage M, Siersema PD, van Dekken H, Steyerberg EW, Dees J, Kuipers EJ. Hage M, et al. Scand J Gastroenterol. 2004 Dec;39(12):1175-9. doi: 10.1080/00365520410003524. Scand J Gastroenterol. 2004. PMID: 15742992

4

Cure of Barrett's carcinoma by ifosfamide chemotherapy.

Hage M, van Dekken H, Siersema PD. Hage M, et al. Eur J Gastroenterol Hepatol. 2003 Jul;15(7):829. doi: 10.1097/01.meg.0000059139.68845.4f. Eur J Gastroenterol Hepatol. 2003. PMID: 12811316 No abstract available.

5

Molecular evaluation of ablative therapy of Barrett's oesophagus.

Hage M, Siersema PD, Vissers KJ, Steyerberg EW, Haringsma J, Kuipers EJ, van Dekken H. Hage M, et al. J Pathol. 2005 Jan;205(1):57-64. doi: 10.1002/path.1685. J Pathol. 2005. PMID: 15586364 Clinical Trial.

6

Genomic analysis of Barrett's esophagus after ablative therapy: persistence of genetic alterations at tumor suppressor loci.

Hage M, Siersema PD, Vissers KJ, Dinjens WN, Steyerberg EW, Haringsma J, Kuipers EJ, van Dekken H. Hage M, et al. Int J Cancer. 2006 Jan 1;118(1):155-60. doi: 10.1002/ijc.21302. Int J Cancer. 2006. PMID: 16032707 Free article.

7

Limited diagnostic value of microsatellite instability associated pathology features in colorectal cancer.

van Putten PG, van Lier MG, Hage M, Biermann K, van Rijssel RH, Westenend PJ, Morreau H, Steyerberg EW, Dinjens WN, Kuipers EJ, van Leerdam ME, van Krieken JH. van Putten PG, et al. Among authors: hage m. Fam Cancer. 2014 Sep;13(3):351-9. doi: 10.1007/s10689-014-9705-8. Fam Cancer. 2014. PMID: 24638969

8

Pathologic diagnostics of HER2 positivity in gastroesophageal adenocarcinoma.

Koopman T, Louwen M, Hage M, Smits MM, Imholz AL. Koopman T, et al. Among authors: hage m. Am J Clin Pathol. 2015 Feb;143(2):257-64. doi: 10.1309/AJCPCX69HGDDGYCQ. Am J Clin Pathol. 2015. PMID: 25596252

9

Sex Differences in Neoplastic Progression in Barrett's Esophagus: A Multicenter Prospective Cohort Study.

Roumans CAM, Zellenrath PA, Steyerberg EW, Lansdorp-Vogelaar I, Doukas M, Biermann K, Alderliesten J, van Ingen G, Nagengast WB, Karrenbeld A, Ter Borg F, Hage M, Ter Borg PCJ, den Bakker MA, Alkhalaf A, Moll FCP, Brouwer-Hol L, van Baarlen J, Quispel R, van Tilburg A, Burger JPW, van Tilburg AJP, Ooms AHAG, Tang TJ, Romberg-Camps MJL, Goudkade D, Bruno MJ, Rizopoulos D, Spaander MCW. Roumans CAM, et al. Among authors: hage m. Cancers (Basel). 2022 Jul 1;14(13):3240. doi: 10.3390/cancers14133240. Cancers (Basel). 2022. PMID: 35805012 Free PMC article.

10

HER2 positivity in gastric and esophageal adenocarcinoma: clinicopathological analysis and comparison.

Koopman T, Smits MM, Louwen M, Hage M, Boot H, Imholz AL. Koopman T, et al. Among authors: hage m. J Cancer Res Clin Oncol. 2015 Aug;141(8):1343-51. doi: 10.1007/s00432-014-1900-3. Epub 2014 Dec 28. J Cancer Res Clin Oncol. 2015. PMID: 25544671

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

404 results

Search Page